IJIsaiah Jamna

Isaiah Jamna

*This is an algorithmically generated author record based on publicly available information.

Isaiah Jamna has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preliminary Analysis of PM2.5 Exposure and Cytokine Expression in Sickle Cell Disease Patients Presenting With Non-Asthmatic Wheezing

    by Isaiah Jamna, Cordale Jimmison, Sarah McCuskee

    Background: Airborne particulate matter <2.5 µm (PM2.5) may trigger inflammation in patients with sensitive immune profiles, particularly Sickle Cell Disease (SCD) patients with nonasthmatic wheezing. The impact and pathophysiology of PM2.5 on these SCD patients is not well understood. This preliminary analysis examines associations between PM2.5 and cytokine expression-the production of immune signaling proteins associated with environmental stressors-in this population. Methods: This is a secondary analysis of data from a cohort of adults with SCD, which included 80 participants with documented non-asthmatic wheezing. Cytokine levels were measured from blood samples using 184-protein multiplex immunoassays. Participants' residential addresses were geocoded and linked to public environmental datasets to estimate exposure to PM2.5. Exploratory associations between PM2.5 exposure and cytokine expression were assessed using longitudinal adjusted linear regression models, corrected for multiple comparisons. Results: Molecular and pathological connections between relevant cytokines were identified using STRING Database, UniProt, KEGG Pathways, and Enrichr. A targeted literature review identified key pathways with inflammatory associations to PM2.5. Preliminary findings suggest that exposure to PM2.5 is associated with differential (both positive and negative) expression of several inflammatory cytokines and chemokines in adults with SCD and non-asthmatic wheezing. This may indicate immune signaling disruption. Conclusion: Pathway analysis and existing literature indicate that mechanisms may include altered macrophage functionality or polarization due to abnormal chemokine signaling and recruitment, adhesion properties, airway epithelial damage, or oxidative stress.

  • Open Access

    Transit Proximity of Individuals Living with Sickle Cell Disease

    by Cordale Jimmison, Isaiah Jamna, Keyonna Robles, Sarah McCuskee

    Background: Sickle Cell Disease (SCD) is a hereditary blood disorder that significantly affects African American urban communities in the United States. This study examines the residential context of individuals with SCD in New York City (NYC), exploring how cardiopulmonary symptoms relate to the proximity to the healthcare center and accessible and non-accessible public transit. Methods: This cross-sectional study was conducted by geocoding addresses of 80 patients (≥18 years) with confirmed SCD in NYC, collected from January to December 2019. Questionnaires recorded symptoms of fatigue and dyspnea severity (rated on a 0 (none)-10 (worst) Likert scale) prior to (baseline) and after (end) completing a 6-minute walk test. Data were stratified by NYC borough. MTA Subway Accessible Station Platform Availability access was extracted from NYOpen Data. Geospatial analysis was conducted in QGIS LTR 3.40.9 by computing linear distance to transit (subway lines, accessible subway stations with elevators) and to the care center from participant addresses. Preliminary descriptive statistics were calculated. Results: Participants identified as female (n = 43, 54%), male (n = 36, 46%), with mean age of 33 (SD = 10.2). Participants identified as Black or African American (n = 66, 81%), Hispanic or Latino (n = 17, 21%), and Other (n = 3, 4%). Mean baseline dyspnea was 0.48 (SD = 0.82) and mean end dyspnea was 1.31 (SD = 1.36). Mean baseline fatigue was mean = 1.07 (SD = 1.44) and mean end fatigue was 1.39 (SD = 1.55). Mean linear distance to the closest subway line was 2.37 miles (SD = 8.79). Mean linear distance to accessible subway stations was 2.65 miles (SD = 9.76). Mean linear distance to the care center was 7.58 miles (SD = 11.07). Conclusions: Patients exhibited increased fatigue and dyspnea after the 6-minute walk test. They reside relatively far from subway lines and accessible subway stations. Future studies should investigate whether transit accessibility influences symptom burden in the SCD population.